Tramadol Other names: Tramadol hydrochloride

Chemical formula: C₁₆H₂₅NO₂  Molecular mass: 263.381 g/mol  PubChem compound: 33741

Therapeutic indications

Tramadol is indicated for:

Moderate to severe pain

Population group: only adults (18 years old or older)

Management (treatment and prevention) of moderate to severe pain.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Moderate to severe pain

Population group: only children (1 year - 12 years old)

Management (treatment and prevention) of moderate to severe pain.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Tramadol is contraindicated in the following cases:

Monoamine oxidase inhibitors

Monoamine oxidase inhibitors (MAOIs)

Epilepsy

Epilepsy

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Structured Product Labeling (SPL/PLR) 2020: ULTRAM Coated tablet
Summary of Product Characteristics (SPC) 2018: TRAMADOL Solution for injection or infusion
Summary of Product Characteristics (SPC) 2022: TRAMAL Capsule, Solution for injection, Tablet
Summary of Product Characteristics (SPC) 2018: TRAMADOL Capsule, hard
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈